A Phase I, Open, Randomised, Single-Centre, Crossover Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) After Oral and Intravenous Administration of 14C-Labelled and Non-Labelled AZD1305 to Healthy Male Volunteers

Trial Profile

A Phase I, Open, Randomised, Single-Centre, Crossover Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) After Oral and Intravenous Administration of 14C-Labelled and Non-Labelled AZD1305 to Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Aug 2008

At a glance

  • Drugs AZD 1305; AZD 1305
  • Indications Atrial fibrillation
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Aug 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 28 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top